Cart
sales@molnova.com
ZM 336372
CAS No. 208260-29-1
ZM 336372( ZM336372 | ZM-336372 )
Catalog No. M13244 CAS No. 208260-29-1
ZM 336372 is a potent, specific inhibitor of Raf isoforms in vitro (c-Raf IC50=70 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 32 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 158 | In Stock |
|
| 50MG | 281 | In Stock |
|
| 100MG | 492 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZM 336372
-
NoteResearch use only, not for human use.
-
Brief DescriptionZM 336372 is a potent, specific inhibitor of Raf isoforms in vitro (c-Raf IC50=70 nM).
-
DescriptionZM 336372 is a potent, specific inhibitor of Raf isoforms in vitro (c-Raf IC50=70 nM), paradoxically induces >100-fold activation of c-Raf (Raf-1 activator), but without triggering any activation of MKK1 or p42 MAPK/ERK2; suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells, with marked induction of the cell cycle inhibitors p21 and p18; blocks cellular proliferation and suppresses NE vasoactive peptide production in pheochromocytoma cells.
-
In Vitro——
-
In Vivo——
-
SynonymsZM336372 | ZM-336372
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorC-Raf
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number208260-29-1
-
Formula Weight389.4
-
Molecular FormulaC23H23N3O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=CC=C(C)C(NC(C2=CC=C(O)C=C2)=O)=C1)C3=CC=CC(N(C)C)=C3
-
Chemical NameBenzamide, 3-(dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hall-Jackson CA, et al. Chem Biol. 1999 Aug;6(8):559-68.
2. Van Gompel JJ, et al. Mol Cancer Ther. 2005 Jun;4(6):910-7.
3. Kappes A, et al. J Surg Res. 2006 Jun 1;133(1):42-5.
4. Kunnimalaiyaan M, et al. Surgery. 2007 Dec;142(6):959-64; discussion 959-64.
molnova catalog
related products
-
BI 882370
BI 882370 is a highly potent, selective, orally active RAF inhibitor with IC50 of 0.4, 0.8 and 0.6 nM for BRAF V600E, BRAF WT and CRAF, respectively.
-
R18
Antagonist of 14.3.3 proteins (KD ≈80 nM). Competitively inhibits 14.3.3-ligand interactions without requiring phosphorylation. Blocks the ability of 14.3.3 to bind to target proteins such as Raf-1, Bad, ASK1 and exoenzyme S.
-
GSK2008607
GSK2008607 is a potent B-RafV600E inhibitor with anticancer activity and can be used to study breast, colorectal, melanoma, thyroid, and ovarian cancers.
